Skip to main content
Equibles

UBS Group AG

Position in LPCN — Lipocine Inc.

CIK 1610520 ZURICH, V8
Back to LPCN Full portfolio

Position in LPCN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$9,205
-$18,711 QoQ
Shares Held
3,596
+2.9% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 36 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LPCN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,801 across 560 Biotechnology names. LPCN ranks #451 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in LPCN

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,205 3,596
2026-03-31 $27,916 3,494
2025-12-31 $44,992 5,603
2025-09-30 $5,032 1,766
2025-06-30 $1,500 475
2025-03-31 $632 199
2024-12-31 $14 3
2024-09-30 $266,763 59,413
2024-06-30 $463,261 56,221
2024-03-31 $2,241 431
2023-09-30 $125 42
2023-03-31 $7,985 25,113
2022-12-31 $4,562 11,463
2022-09-30 $225 500
2022-06-30 $400 500
2022-03-31 $10,085 7,362
2021-12-31 $3,964 4,000
2021-09-30 $2,260 2,074
2021-06-30 $9,499 6,785
2021-03-31 $3,020 2,000
2020-12-31 $2,040 1,500
2020-09-30 $2,115 1,500
2020-06-30 $1,260 1,000
2020-03-31 $1,574 3,281